Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Molecular and Biochemical Parasitology
|
July 1, 1995
Molecular analysis of two hexokinase isoenzymes from Entamoeba histolytica
S Ortner, B Plaimauer, M Binder, et al.
Molecular and Biochemical Parasitology
|
May 1, 1995
Sequence and organization of an unusual histone H4 gene in the human parasite Entamoeba histolytica
M Binder, S Ortner, B Plaimauer, et al.
Archives of Medical Research
|
January 1, 1992
Molecular characterization of IgG and IgE antigens of Entamoeba histolytica
B Plaimauer, S Ortner, M Födinger, et al.
Journal of Thrombosis and Haemostasis : JTH
|
November 3, 2011
Inverse correlation of free and immune complex-sequestered anti-ADAMTS13 antibodies in a patient with acquired thrombotic thrombocytopenic purpura
S Ferrari, P Knöbl, V Kolovratova, et al.
Thrombosis Research
|
February 25, 2000
Recombinant human factor X: high yield expression and the role of furin in proteolytic maturation in vivo and in vitro
M Himmelspach, M Pfleiderer, B E Fischer, et al.
Seminars in Thrombosis and Hemostasis
|
September 8, 2001
Recombinant von Willebrand factor: preclinical development
B Plaimauer, U Schlokat, P L Turecek, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 22, 2014
A novel flow-based assay reveals discrepancies in ADAMTS-13 inhibitor assessment as compared with a conventional clinical static assay
R Grillberger, B Gruber, S Skalicky, et al.
Journal of Thrombosis and Haemostasis : JTH
|
May 5, 2005
Cloning, expression and functional characterization of the full-length murine ADAMTS13
K Bruno, D Völkel, B Plaimauer, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 8, 2011
Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies
B Plaimauer, J A Kremer Hovinga, C Juno, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 3, 2016
Preclinical assessment of a new recombinant ADAMTS-13 drug product (BAX930) for the treatment of thrombotic thrombocytopenic purpura
A Kopić, K Benamara, C Piskernik, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Molecular and Biochemical Parasitology
|
July 1, 1995
Molecular analysis of two hexokinase isoenzymes from Entamoeba histolytica
S Ortner, B Plaimauer, M Binder, et al.
Molecular and Biochemical Parasitology
|
May 1, 1995
Sequence and organization of an unusual histone H4 gene in the human parasite Entamoeba histolytica
M Binder, S Ortner, B Plaimauer, et al.
Archives of Medical Research
|
January 1, 1992
Molecular characterization of IgG and IgE antigens of Entamoeba histolytica
B Plaimauer, S Ortner, M Födinger, et al.
Journal of Thrombosis and Haemostasis : JTH
|
November 3, 2011
Inverse correlation of free and immune complex-sequestered anti-ADAMTS13 antibodies in a patient with acquired thrombotic thrombocytopenic purpura
S Ferrari, P Knöbl, V Kolovratova, et al.
Thrombosis Research
|
February 25, 2000
Recombinant human factor X: high yield expression and the role of furin in proteolytic maturation in vivo and in vitro
M Himmelspach, M Pfleiderer, B E Fischer, et al.
Seminars in Thrombosis and Hemostasis
|
September 8, 2001
Recombinant von Willebrand factor: preclinical development
B Plaimauer, U Schlokat, P L Turecek, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 22, 2014
A novel flow-based assay reveals discrepancies in ADAMTS-13 inhibitor assessment as compared with a conventional clinical static assay
R Grillberger, B Gruber, S Skalicky, et al.
Journal of Thrombosis and Haemostasis : JTH
|
May 5, 2005
Cloning, expression and functional characterization of the full-length murine ADAMTS13
K Bruno, D Völkel, B Plaimauer, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 8, 2011
Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies
B Plaimauer, J A Kremer Hovinga, C Juno, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 3, 2016
Preclinical assessment of a new recombinant ADAMTS-13 drug product (BAX930) for the treatment of thrombotic thrombocytopenic purpura
A Kopić, K Benamara, C Piskernik, et al.
Page
of 3